A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Lifevantage Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 19,531 shares of LFVN stock, worth $129,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,531
Previous 17,847 9.44%
Holding current value
$129,099
Previous $233,000 18.45%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$9.73 - $14.51 $16,385 - $24,434
1,684 Added 9.44%
19,531 $190,000
Q2 2025

Aug 14, 2025

BUY
$11.18 - $16.05 $5,377 - $7,720
481 Added 2.77%
17,847 $233,000
Q1 2025

May 15, 2025

BUY
$14.42 - $25.62 $97,666 - $173,524
6,773 Added 63.94%
17,366 $253,000
Q4 2024

Feb 14, 2025

BUY
$11.34 - $17.85 $120,124 - $189,085
10,593 New
10,593 $185,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $83M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.